Novartis Ag NVS

NYSE NVS

$137.50 -0.20 (-0.15%)

As of: Sep 9, 2026 · 3:59 PM EDT

Novartis Ag (NVS) Shares Outstanding (Entity) (2009 - 2025)

Analysis

Novartis Ag (NVS) Shares Outstanding (Entity) (2009 - 2025) Analysis & Trends

Peer Set

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Outstanding (Entity.) (Qtr)
1	Johnson & Johnson	663.08 Bn	642.33 Bn	17.26 Bn	2.41 Bn
2	AbbVie	453.04 Bn	446.51 Bn	12.70 Bn	1.77 Bn
3	Merck	370.87 Bn	363.78 Bn	12.21 Bn	2.47 Bn
4	Novartis Ag	305.29 Bn	298.00 Bn	11.24 Bn	-
5	Pfizer	162.10 Bn	150.70 Bn	10.94 Bn	5.70 Bn
6	Sanofi	53.95 Bn	46.98 Bn	10.79 Bn	-
7	Revolution Medicines	45.00 Bn	45.00 Bn	-	214.24 Mn
8	Incyte	25.47 Bn	20.94 Bn	1.57 Bn	200.98 Mn
9	United Therapeutics	20.81 Bn	18.15 Bn	683.80 Mn	42.68 Mn
10	Jazz Pharmaceuticals	16.02 Bn	14.40 Bn	1.09 Bn	64.91 Mn

Historic Data

Historic Data

Download Data

Date	Value
Dec 31, 2025	1.91 Bn
Dec 31, 2024	1.98 Bn
Dec 31, 2023	2.04 Bn
Dec 31, 2022	2.12 Bn
Dec 31, 2021	2.23 Bn
Dec 31, 2020	2.26 Bn
Dec 31, 2019	2.27 Bn
Dec 31, 2018	2.31 Bn
Dec 31, 2017	2.32 Bn
Dec 31, 2016	2.37 Bn
Dec 31, 2015	2.37 Bn
Dec 31, 2014	2.40 Bn
Dec 31, 2013	2.43 Bn
Dec 31, 2012	2.42 Bn
Dec 31, 2011	2.41 Bn
Dec 31, 2010	2.29 Bn
Dec 31, 2009	2.27 Bn

Novartis Ag

NYSE: NVS

$137.50 ▼ -0.20 (-0.15%)

Sep 9, 2026 · 3:59 PM EDT